Diarrhea

Regarding side effects and tolerability of β blockers, Kotecha and colleagues state: “Although β blockers are often associated with side effects, data from randomised trials consistently show no true difference compared with placebo in dizziness, diarrhoea, increased blood sugar concentration, or depression …  

Regarding side effects and tolerability of β blockers, Kotecha and colleagues state: “Although β blockers are often associated with side effects, data from randomised trials consistently show no true difference compared with placebo in dizziness, diarrhoea, increased blood sugar concentration, or depression …  

Regarding side effects and tolerability of β blockers, Kotecha and colleagues state: “Although β blockers are often associated with side effects, data from randomised trials consistently show no true difference compared with placebo in dizziness, diarrhoea, increased blood sugar concentration, or depression …  

How an over-the-counter medication for diarrhea has become a worrying and potentially lethal drug of abuse.  

Prophylactic antibiotic use is only recommended for patients vulnerable to severe sequelae after a short period of diarrhoea, such as those with ileostomies or immune suppression  

Prophylactic antibiotic use is only recommended for patients vulnerable to severe sequelae after a short period of diarrhoea, such as those with ileostomies or immune suppression  

Prophylactic antibiotic use is only recommended for patients vulnerable to severe sequelae after a short period of diarrhoea, such as those with ileostomies or immune suppression  

Prophylactic antibiotic use is only recommended for patients vulnerable to severe sequelae after a short period of diarrhoea, such as those with ileostomies or immune suppression  

Microscopic colitis is diagnosed in a 64-year-old woman with a history of watery diarrhea. What is the most appropriate treatment option?  

Abstract and Introduction: Shiga toxin 1-producing Shigella sonnei infection, often causing bloody diarrhea, has recently emerged in California and may spread in the United States.  

This activity was developed for gastroenterologists with an interest in the management of irritable bowel syndrome with diarrhea (IBS-D). Other healthcare providers may also participate.  

How do you manage diarrhea, fatigue, rash, and other adverse effects associated with anti-PD-1/anti-PD-L1 therapies?  

Strongyloides stercoralis is a parasite that lives in the gut of infected people. The infection is not serious for most people, but it can be fatal in people with immune deficiency. People become infected when they come in contact with soil or water contaminated with infectious worms. The chronic infection usually causes skin rash, vomiting, diarrhoea, and constipation, and respiratory problems, such as asthma-like illness. This disease may be treated with ivermectin or albendazole or thiabendazole. We wanted to know if ivermectin was better or worse than the other alternative therapies.  

A 25-year-old woman presents with diarrhea x 3 weeks. She has reports 6-12 loose bowel movements per day with urgency and mucous which are associated with cramping abdominal pain and a 5lb weight loss. She has not noticed any blood in her stool and reports no other extra-intestinal manifestations of inflammatory bowel disease (IBD). She has not travelled recently and drinks out of a municipal water supply. None of her contacts have similar symptoms and she has had no changes to her diet. She has no family history of IBD but does have a family history of a variety of autoimmune conditions.  She is otherwise healthy and has had no recent contact with the health care system or use of antibiotics. Her vital signs are normal, she looks well and her abdominal exam is normal.  

Studies suggest a new oral agent with mixed opioid effects may be a promising new option for irritable bowel syndrome with diarrhea; its approval adds to the growing list of options for the disorder.  

Could resetting microbial diversity via rifaximin lead to a decrease in bacterial fermentation and a reduction in the clinical symptoms of IBS?  

Dr Asim Amin, codirector of immunotherapy at Levine Cancer Institute, discusses the management of gastrointestinal side effects of immunotherapy.  

Six year old Angela comes into your department with a three day history of diarrhoea and vomiting. You determine that she needs cannulation both to assess her renal function and to begin treatment. You know that cannulating children can be a painful and traumatic experience and are keen to make it as stress-free as possible. The nurses ask you what you would like them to put on the child?  

Some patients with ulcerative colitis have their colon and rectum removed with construction of a pouch (made from a loop of small intestine) to serve in place of the rectum. This is known as ileal pouch-anal anastomosis (IPAA) surgery. Pouchitis is inflammation of the surgically constructed pouch. Symptoms of active pouchitis include diarrhea, increased stool frequency, abdominal cramping, fecal urgency, tenesmus (feeling of constantly needing to pass stools), and incontinence. Periods when symptoms stop are called 'remission'.  

A 51 year old man is brought to your ED by his family. He has been slightly confused and also had diarrhoea and vomiting for the last three days.